-transparent.png){kind=logo}
In Japan the regimen with peplomycin has been mainly used for the treatment of squamous cell carcinoma (SCC). But recently, a regimen with cisplatin, particularly the combination of cisplatin and adriamycin (CA chemotherapy) has been used for the treatment of SCC, and a better prognosis has resulted Since CA chemotherapy is very effective for not only SCC, but also basal cell carcinoma (BCC), we think it is a prominent neoadjuvant therapy for SCC and BCC. We have used CA chemotherapy for multiple lung metastasis of BCC over the past six years, and three times PR was obtained, with survival so far.
Related Publications
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
February 2003,
Seminars in oncology nursing,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
June 2000,
Primary care,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
December 2006,
The Practitioner,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
March 1998,
Oral oncology,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
January 2006,
Frontiers of radiation therapy and oncology,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
January 1986,
The Medical clinics of North America,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
August 2015,
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
September 1991,
International journal of clinical pharmacology, therapy, and toxicology,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
October 1975,
British journal of plastic surgery,
S Ikeda, and
T Suzuki, and
Y Kiyohara, and
A Kuramochi
March 1989,
Boletin de la Asociacion Medica de Puerto Rico,
